160 related articles for article (PubMed ID: 7682054)
1. Aprotinin in perspective.
Westaby S
Ann Thorac Surg; 1993 Apr; 55(4):1033-41. PubMed ID: 7682054
[TBL] [Abstract][Full Text] [Related]
2. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass.
van Oeveren W; Harder MP; Roozendaal KJ; Eijsman L; Wildevuur CR
J Thorac Cardiovasc Surg; 1990 May; 99(5):788-96; discussion 796-7. PubMed ID: 1691806
[TBL] [Abstract][Full Text] [Related]
3. Activation of hemostasis during cardiopulmonary bypass and pediatric aprotinin dosage.
Mössinger H; Dietrich W
Ann Thorac Surg; 1998 Jun; 65(6 Suppl):S45-50; discussion S50-1, S74-6. PubMed ID: 9647138
[TBL] [Abstract][Full Text] [Related]
4. Reducing thrombin formation during cardiopulmonary bypass: is there a benefit of the additional anticoagulant action of aprotinin?
Dietrich W
J Cardiovasc Pharmacol; 1996; 27 Suppl 1():S50-7. PubMed ID: 8938284
[TBL] [Abstract][Full Text] [Related]
5. Effects of nafamostat mesilate and minimal-dose aprotinin on blood-foreign surface interactions in cardiopulmonary bypass.
Kaminishi Y; Hiramatsu Y; Watanabe Y; Yoshimura Y; Sakakibara Y
Ann Thorac Surg; 2004 Feb; 77(2):644-50. PubMed ID: 14759453
[TBL] [Abstract][Full Text] [Related]
6. Aprotinin preserves hemostasis in aspirin-treated patients undergoing cardiopulmonary bypass.
Tabuchi N; Huet RC; Sturk A; Eijsman L; Wildevuur CR
Ann Thorac Surg; 1994 Oct; 58(4):1036-9. PubMed ID: 7524460
[TBL] [Abstract][Full Text] [Related]
7. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss.
Santamaría A; Mateo J; Oliver A; Litvan H; Murillo J; Souto JC; Fontcuberta J
Haematologica; 2000 Dec; 85(12):1277-84. PubMed ID: 11114135
[TBL] [Abstract][Full Text] [Related]
8. Is use of aprotinin safe with deep hypothermic circulatory arrest in aortic surgery? Investigations on blood coagulation.
Okita Y; Takamoto S; Ando M; Morota T; Yamaki F; Kawashima Y
Circulation; 1996 Nov; 94(9 Suppl):II177-81. PubMed ID: 8901742
[TBL] [Abstract][Full Text] [Related]
9. Aprotinin and hemostasis monitoring concerns during cardiac surgery.
Swartz MF; Fink GW; Searles B
J Extra Corpor Technol; 2004 Dec; 36(4):375-83. PubMed ID: 15679283
[TBL] [Abstract][Full Text] [Related]
10. Aprotinin reduces intraoperative and postoperative blood loss in membrane oxygenator cardiopulmonary bypass.
Harder MP; Eijsman L; Roozendaal KJ; van Oeveren W; Wildevuur CR
Ann Thorac Surg; 1991 Jun; 51(6):936-41. PubMed ID: 1710098
[TBL] [Abstract][Full Text] [Related]
11. Is reduced systemic heparinization justified with heparin-bonded bypass circuits in cardiac surgery?--Experience with and without aprotinin.
Kipfer B; Englberger L; Gygax E; Nydegger U; Carrel T
Transfus Apher Sci; 2003 Aug; 29(1):17-24. PubMed ID: 12877888
[TBL] [Abstract][Full Text] [Related]
12. Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations.
Dietrich W; Mössinger H; Spannagl M; Jochum M; Wendt P; Barankay A; Meisner H; Richter JA
J Thorac Cardiovasc Surg; 1993 Apr; 105(4):712-20. PubMed ID: 7682267
[TBL] [Abstract][Full Text] [Related]
13. Aprotinin in coronary operation with cardiopulmonary bypass: does "low-dose" aprotinin inhibit the inflammatory response?
Englberger L; Kipfer B; Berdat PA; Nydegger UE; Carrel TP
Ann Thorac Surg; 2002 Jun; 73(6):1897-904. PubMed ID: 12078788
[TBL] [Abstract][Full Text] [Related]
14. Platelet preservation during cardiopulmonary bypass with aprotinin.
Wildevuur CR; Eijsman L; Roozendaal KJ; Harder MP; Chang M; van Oeveren W
Eur J Cardiothorac Surg; 1989; 3(6):533-7; discussion 537-8. PubMed ID: 2483979
[TBL] [Abstract][Full Text] [Related]
15. Aprotinin complements heparin bonding in an in vitro model of cardiopulmonary bypass.
Bannan S; Martin PG
Br J Haematol; 1998 Jun; 101(3):455-61. PubMed ID: 9633886
[TBL] [Abstract][Full Text] [Related]
16. Monitoring of anticoagulation in aprotinin-treated patients during heart operation.
Tabuchi N; Njo TL; Tigchelaar I; Huyzen RJ; Boonstra PW; van Oeveren W
Ann Thorac Surg; 1994 Sep; 58(3):774-7. PubMed ID: 7524456
[TBL] [Abstract][Full Text] [Related]
17. Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass.
Kawasuji M; Ueyama K; Sakakibara N; Tedoriya T; Matsunaga Y; Misaki T; Watanabe Y
Ann Thorac Surg; 1993 May; 55(5):1205-9. PubMed ID: 7684219
[TBL] [Abstract][Full Text] [Related]
18. Aprotinin effect on platelet function and clotting during cardiopulmonary bypass.
Tabuchi N; De Haan J; Boonstra PW; Huet RC; van Oeveren W
Eur J Cardiothorac Surg; 1994; 8(2):87-90. PubMed ID: 7513534
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a novel kallikrein inhibitor on hemostatic activation in vitro.
Tanaka KA; Szlam F; Katori N; Vega JD; Levy JH
Thromb Res; 2004; 113(5):333-9. PubMed ID: 15183046
[TBL] [Abstract][Full Text] [Related]
20. Reheparinisation requirements after cardiopulmonary bypass in patients treated with aprotinin.
Bailey CR; Fisher AR; Wielogorski AK
Br Heart J; 1994 Nov; 72(5):442-5. PubMed ID: 7529520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
